Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
David Gionco currently holds 327,878 shares of STEMLINE THERAPEUTICS INC (STML), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, David Gionco has been a net seller of STML stock. They have purchased $0 and sold $1.5M worth of shares.
David Gionco's most recent insider trade was on Jun 10, 2020, when they sold 45,000 shares at $0.00 per share.
David Gionco serves as Executive at STEMLINE THERAPEUTICS INC (STML). They have executed 63 insider transactions totaling $1.5M over their tenure at the company.
David Gionco holds the position of Executive at STEMLINE THERAPEUTICS INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 17 years and currently hold a stake valued at $0.
David Gionco has shown a selling trading pattern, with $0 in total purchases and $1.5M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by David Gionco was on Sep 16, 2010, when they purchased $464.5K worth of SVNT shares. This transaction involved 22,918 shares at $20.27 per share.
David Gionco currently owns 327,878 shares of STEMLINE THERAPEUTICS INC (STML), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of David Gionco's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. David Gionco has 63 Form 4 filings on record as an insider at STEMLINE THERAPEUTICS INC.
Set alerts for David Gionco and 40,000+ other insiders.